Gossamer Bio Earnings
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.31-0.57 (-5.77%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-5.55
Gossamer Bio earnings summary
Gossamer Bio is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-5.55.
Summary generated from market data by MetaCap's automated system. Methodology